SIP

Sigma Pharmaceuticals (SIP)

Stock Code

SIP

Stock Exchange

Australian Securities Exchange

Sigma Pharmaceuticals Limited (SIP) is a company engaged in manufacturing, marketing and distributing pharmaceutical products through drugstore and grocery channels. SIP also provides services to retail pharmacists. SIP was listed on the Australian Stock Exchange on the 30th of October 2002. Its average annual revenue reaches approximately $2.9 billion out of its issued capital of approximately $3.6 million. Its headquarters is located in Victoria, Australia and to date; around 2000 people are employed in the company.

2011's Last Best and Worst Traded Stocks


As the year 2011 closed, share prices continued to fluctuate as companies and investors continue to trade stocks. This is a record of the best and worst traded stocks in the indices ASX100, ASX200 and All Ordinaries in the Australian Securities Exchange in the last week of 2011, December 26 to 30, 2011.

Best Performing Trade Stocks ASX100 (XTO)

ASX100

Sigma Chases Deal to Deprive Rival of 10 percent Revenue


Sigma Pharmaceuticals Limited (SIP) proceeds with a deal that will slash 10 percent of its rival’s revenue. The ailing drug wholesaler is catering to Australian Pharmacy Alliance, to cut off its rival Australian Pharmaceutical Industries from its biggest customer.

Pfizer Pharmaceutical Wholesale Business


Pharmaceuticals conglomerate, Pfizer have decided to distribute its products directly to chemists.

Sigma Pharmaceuticals Loses Wholesale Revenue


Pharma manufacturing and distribution company, Sigma Pharmaceuticals (ASX:SIP) has revealed that the company will lose 10 to 15 percent of wholesale revenue from February 2011 after a decision from Pfizer to directly distribute its prescription medicines directly to the chemists. Sigma stated in a statement on Monday: "All prescription products (PBS and non PBS) will be delivered by Pfizer direct to pharmacies.

Sigma Pharmaceuticals Writedown


Drugmaker, Sigma Pharmaceuticals (ASX:SIP) have seen their shares fall after the company announced that it expected a $270 million impairment charge on the sale of its pharmaceutical division might affect its current loan facilities. This announcement follows a decision last month to sell the business for less than its book value. The writedown is unlikely to stop the sale of the business to South Africa's Aspen Pharmacare for $900m.

Sigma Pharmaceuticals Dividends

1 September, 2010 - 12:40

Peruse the dividend history for SIGMA PHARMACEUTICALS LIMITED. Dividends are a portion of company profits paid out to shareholders. You are eligible to receive SIP dividends if you own the SIGMA PHARMACEUTICALS LIMITED shares on the ex-dividend date. Traders and investors must purchase the stock before the exdividend date to be entitled to the dividend. The previous owner of the shares will receive the SIP dividend if you buy the stocks on or after the ex dividend date.

Hot Stocks ASX 200


Hot stocks for this week of the top 10 Australian shares which are in the ASX 200. Among the hot stocks this week included: AXA ASIA PACIFIC HOLDINGS LIMITED, ALUMINA LIMITED, ISOFT GROUP LIMITED, Myer Holdings, SIGMA PHARMACEUTICALS LIMITED, TRANSURBAN GROUP, Eldorado Gold Corporation, LYNAS CORPORATION LIMITED, AVOCA RESOURCES LIMITED, JB HI-FI LIMITED.

ASX 200 Bottom 10 Companies of Australian Share Market


Here are the ASX 200 bottom 10 stocks which decreased value on the share market, the Australian Securities Exchange (ASX) this 28th week of 2010:

Which ASX 200 Stocks Increased Value Last Week?


Here are the top 10 ASX 200 stocks which increased value on the Australian Securities Exchange (ASX) this 27th week of 2010:

Syndicate content

Download our FREE App


Signup for Free
Don't miss out on your free share trading articles.


Free Risk Money Management Calculator for those who sign up!